Minimal to undetectable increases in LPS-specific serum IgG3 and IgG4 responses were observed throughout the study with no significant differences at any time point or across shigellosis outcome within treatment group (Supplemental Fig. S2c). Here, IGHG3 is linked to shigellosis.